Pykus Therapeutics, Inc., a clinical-stage medical technology company developing a novel retinal sealant, PYK-2101, to replace gas and oil during retinal detachment repair, today announced that it ...
The only treatment option currently available is vitrectomy. Pharmacologic treatment options have advanced over the past decade, and the current strategy of 'watchful waiting' until symptoms ...